Skip to main content

Biologie und Pathologie fortgeschrittener Tumoren

  • Chapter
Book cover Palliative Krebstherapie
  • 16 Accesses

Zusammenfassung

Der Prozeß eines Tumorleidens stellt eine komplexe Sequenz von Ereignissen dar, in deren Rahmen zahlreiche biologische Interaktionen zwischen dem Tumorgewebe und dem Wirtsorganismus ablaufen. Sieht man von Patienten mit einem lokal ausgedehnten Tumorgeschehen ab, das über die Freisetzung von biologisch aktiven Mediatoren die Physiologie des Gesamtorganismus beeinflussen kann, so wird die fortgeschrittene Tumorerkrankung in erster Linie durch den Prozeß der Metastasierung bestimmt. Trotz aller Fortschritte bei der operativen Behandlung des Primärtumors und den Bemühungen urn eine (adjuvante) Chemo- und Radiotherapie stellt die Metastasierung bei vielen bösartigen Organtumoren mehr denn je die häufigste Todesursache eines Krebspatienten dar. Von daher gesehen kommt dem Verständnis der Mechanismen, mit den en Zellen eines malignen Tumors zu Metastasen führen, eine zentrale Bedeutung für die Biologie und Pathologie eines fortschreitenden und fortgeschrittenen Tumorleidens zu. Somit stellt die Metastasenforschung heute für die klinische und experimentelle Onkologie eine der großen Herausforderungen dar, der sich in den letzten lahren die unterschiedlichsten Forschungszweige gestellt haben und zu der inzwischen eine Fülle von neuen Erkenntnissen vermittelt wurde [Übersichten: 18, 21, 36, 42, 50, 51, 55].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Auerbach R (1988) Patterns of metastasis: organ selectivity in the spread of cancer cells. Lab Invest 58: 361–364

    PubMed  CAS  Google Scholar 

  2. Azzarelli B, Easterling K, Norton JA (1989) Leukemic cell interactions in leukemic cell dissemination. Lab Invest 60: 45–64

    PubMed  CAS  Google Scholar 

  3. Beuth J, Ko HL, Oette K, Pulverer G, Roszkowski K, Uhlenbruck G (1987) Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose. J Cancer Res Clin Oncol 113: 51–55

    Article  PubMed  CAS  Google Scholar 

  4. Beuth J, Ko HL, Pulverer G, Uhlenbruck G (1988) Bedeutung der Lektine für Tumormetastasen und bakterielle Infektionen. Med Klin 83: 682–686

    CAS  Google Scholar 

  5. Bishop JM (1987) The molecular genetics of cancer. Science 235: 305–311

    Article  PubMed  CAS  Google Scholar 

  6. Braun OM, Neumeister B, Popp W et al. (1989) Histologic tumor regression grades in squamous cell carcinoma of the head and neck after preoperative radiochemotherapy. Cancer 63: 1097–1100

    Article  PubMed  CAS  Google Scholar 

  7. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24740 breast cancer cases. Cancer 63: 181–187

    Article  PubMed  CAS  Google Scholar 

  8. Cifone MA, Fidler IJ (1981) Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci USA 78: 6949–6952

    Article  PubMed  CAS  Google Scholar 

  9. De La Monte S, Hutchins GM, Moore GW (1988) Altered metastatic behavior of small cell carcinoma of the lung after chemotherapy and radiation. Cancer 61: 2176–2182

    Article  PubMed  Google Scholar 

  10. Denk H (1988) Immunohistologic heterogeneity of malignant tumors. Pathol Res Pract 183: 693–697

    Article  PubMed  CAS  Google Scholar 

  11. Dennis JW, Laferte S (1987) Tumor cell surface carbohydrate and metastatic phenotype. Cancer Metastasis Rev 5: 185–204

    Article  PubMed  CAS  Google Scholar 

  12. Dennis J, Waller C, Timpl R, Schirrmacher V (1982) Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature 300: 274–276

    Article  PubMed  CAS  Google Scholar 

  13. Dingemans KP (1988) What’s new in the ultrastructure of tumor invasion in vivo? Pathol Res Pract 183: 792–808

    Article  PubMed  CAS  Google Scholar 

  14. Eder M (1984) Die Metastasierung: Fakten und Probleme aus humanpathologischer Sicht. Verh Dtsch Ges Pathol 68: 1–11

    Google Scholar 

  15. Ewing J (1928) A treatise on tumours. 3rd edn. Saunders, Philadelphia

    Google Scholar 

  16. Fearon ER, Hamilton SR, Vogelstein B (1987) Clonal analysis of human colorectal tumors. Science 238: 193–197

    Article  PubMed  CAS  Google Scholar 

  17. Fialkow PJ (1976) Clonal origin of human tumors. Biochim Biophys Acta 458: 283–321

    PubMed  CAS  Google Scholar 

  18. Fidler IJ, Balch CM (1987) The biology of cancer metastasis and implications for therapy. Curr Probl Surg 24: 137–209

    Article  Google Scholar 

  19. Fidler IJ, Hart IR (1982) Biological diversity in metastatic neoplasms: origins and implications. Science 217: 998–1003

    Article  PubMed  CAS  Google Scholar 

  20. Fidler IJ, Poste G (1985) The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy. Semin Oncol 12: 207–221

    PubMed  CAS  Google Scholar 

  21. Fuchshuber P (1985) Experimentelle Untersuchungen zum Wachstumsverhalten von Metastasen des transplantablen Mammacarcinoms HB der C-3 H-Maus. Med Dissertation, Universität Köln

    Google Scholar 

  22. Gabbert H (1985) Mechanism of tumor invasion: evidence from in vivo observation. Cancer Metastasis Rev 4: 293–309

    Article  PubMed  CAS  Google Scholar 

  23. Gabius HJ, Engelhardt R, Casper J et al. (1985) Cell surface lectins of transplantable human teratocarcinoma cells: purification of a new mannan-specific endogenous lectin. Tumour Biol 6: 145–156

    PubMed  CAS  Google Scholar 

  24. Gabius HJ, Engelhardt R, Cramer F (1986) Endogenous tumor lectins: a new class of tumor markers and target for therapy. Med Hypotheses 18: 47–53

    Article  Google Scholar 

  25. Goldie JH, Coldman AJ (1984) The genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Res 44: 3643–3653

    PubMed  CAS  Google Scholar 

  26. Harris M, Howell A, Chrissohou M, Swindell RIC, Hudson M, Sellwood RA (1984) A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 50: 23–30

    Article  PubMed  CAS  Google Scholar 

  27. Heppner GH (1984) Tumor heterogeneity. Cancer Res 44: 2259–2265

    PubMed  CAS  Google Scholar 

  28. Iozzo RV (1988) Proteoglycans and neoplasia. Cancer Metastasis Rev 7: 39–50

    Article  PubMed  CAS  Google Scholar 

  29. Kawaguchi T, Nakamura K (1986) Analysis of the lodgement and extravasation of tumor cells in experimental models of hematogenous metastasis. Cancer Metastasis Rev 5: 77–94

    Article  PubMed  CAS  Google Scholar 

  30. Kieran MW, Longenecker BM (1983) Organ specific metastasis with special reference to avian systems. Cancer Metastasis Rev 2: 165–182

    Article  PubMed  CAS  Google Scholar 

  31. Kunze E, Reckels M, Eiardt B (1985) Der hämatogene Metastasierungsmodus des Bronchialkarzinoms in Abhängigkeit von der Tumorgröße und vom metastatischen Knotenbefall. Eine Autopsiestudie. Pathologe 6: 71–79

    PubMed  CAS  Google Scholar 

  32. Liotta LA (1986) Tumor invasion and metastases - role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res 46: 1–7

    Article  PubMed  CAS  Google Scholar 

  33. Löhrs U (1986) Heterogenität von Metastasen. In: Schildberg FW (Hrsg) Chirurgische Behandlung von Tumormetastasen. Melsunger Medizinische Mitteilungen, Bd 58, S 31–45

    Google Scholar 

  34. Lotan R, Raz A (1983) Low colony formation in vivo and in culture as exhibited by metastatic melanoma cells selected for reduced homotypic aggregation. Cancer Res 43: 2088–2093

    PubMed  CAS  Google Scholar 

  35. Martinez-Hernandez A (1988) The extracellular matrix and neoplasia. Lab Invest 58: 609–612

    PubMed  CAS  Google Scholar 

  36. McMillan TJ, Hart IR (1987) Why do tumours metastasize? Bailliere’s Clin Oncol 1: 461–471

    Google Scholar 

  37. Miller FR (1982) Intratumor immunologic heterogeneity. Cancer Metastasis Rev 1: 319–334

    Article  PubMed  CAS  Google Scholar 

  38. Müller K-M, Fisseler-Eckhoff A (1989) What’s new in lung tumor heterogeneity? Pathol Res Pract 184: 108–115

    Article  Google Scholar 

  39. Nagel GA, Ammon A, Holtkamp W, Meyer D (1989) Klinische Modellvorstellung der Evolution maligner Tumoren: Implikationen für die Hormontherapie des Mammakarzinoms. Onkologie 12: 69–80

    Article  PubMed  CAS  Google Scholar 

  40. Nicolson GL (1984) Cell surface molecules and tumor metastasis. Regulation of metastatic phenotypic diversity. Exp Cell Res 150: 3–22

    Article  PubMed  CAS  Google Scholar 

  41. Nicolson GL (1987) Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res 47: 1473–1487

    PubMed  CAS  Google Scholar 

  42. Nicolson GL (1988) Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at secondary sites. Cancer Metastasis Rev 7: 143–188

    Article  PubMed  CAS  Google Scholar 

  43. Nicolson GL, Winkelhake JL (1975) Organ specificity of blood-borne tumour metastasis determined by cell adhesion? Nature 255: 230–232

    Article  PubMed  CAS  Google Scholar 

  44. Nowell PC (1986) Mechanisms of tumor progression. Cancer Res 46: 2203–2207

    PubMed  CAS  Google Scholar 

  45. Osborne CK (1985) Heterogeneity in hormone receptor status in primary and metastatic breast cancer. Semin Oncol 12: 317–326

    PubMed  CAS  Google Scholar 

  46. Paget S (1889) The distribution of secondary growth in cancer of the breast. Lancet I: 571–573

    Article  Google Scholar 

  47. Pauli BU, Knudson W (1988) Tumor invasion: a consequence of destructive and compositional matrix alterations. Hum Pathol 19: 628–639

    Article  PubMed  CAS  Google Scholar 

  48. Pauli BU, Lee C-L (1988) Organ preference of metastasis. The role of organ-specifically modulated endothelial cells. Lab Invest 58: 379–387

    PubMed  CAS  Google Scholar 

  49. Poste G (1986) Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Cancer Treat Rep 70: 183–199

    PubMed  CAS  Google Scholar 

  50. Poste G, Fidler IJ (1980) The pathogenesis of cancer metastasis. Nature 283: 139–146

    Article  PubMed  CAS  Google Scholar 

  51. Pulverer G, Beuth J, Ko HL, Yassin A, Ohshima Y, Roszkowski K, Uhlenbruck G (1988) Glycoprotein modification of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice. J Cancer Res Clin Oncol 114: 217–220

    Article  PubMed  CAS  Google Scholar 

  52. Raz A, Lotan R (1987) Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev 6: 433–452

    Article  PubMed  CAS  Google Scholar 

  53. Roggli VL, Vollmer RT, Greenberg SO, McGavran MH, Spjut HJ, Yesner R (1985) Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol 16: 569–579

    Article  PubMed  CAS  Google Scholar 

  54. Roos E (1984) Cellular adhesion, invasion and metastasis. Biochim Biophys Acta 738: 263–284

    PubMed  CAS  Google Scholar 

  55. Schirrmacher V (1985) Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv Cancer Res 43: 1–73

    Article  PubMed  CAS  Google Scholar 

  56. Schirrmacher V (1986) Entstehung metastatischer Tumorzellen durch Verschmelzung mit Wirtszellen. In: Deutsches Krebsforschungszentrum (Hrsg) Krebsforschung heute

    Google Scholar 

  57. Schirrmacher V, Altevogt P, Fogel M et al. (1982) Importance of cell surface carbohydrates in cancer cell adhesion, invasion and metastasis. Does sialic acid direct metastatic behavior? Invasion Metastasis 2: 313–360

    CAS  Google Scholar 

  58. Seifert G (1983) Zur Pathomorphologie der hämatogenen Metastasierung. Pathologe 4: 194–203

    PubMed  CAS  Google Scholar 

  59. Thorgeirsson U, Turpeenniemi-Hujanen T, Liotta LA (1985) Cancer cells, components of basement membranes, and proteolytic enzymes. Int Rev Exp Pathol 27: 203–234

    PubMed  CAS  Google Scholar 

  60. Uehlinger E (1965) Das Lungenkarzinom: Metastasensyndrome. Bibl Tuberc 20: 99–122

    PubMed  CAS  Google Scholar 

  61. Uhlenbruck G, Beuth J, Oette K, Roszkowski W, Ko HL, Pulverer G (1986) Prevention of experimental liver metastases by arabinogalactan. Naturwissenschaften 73: 626–627

    Article  PubMed  CAS  Google Scholar 

  62. Uhlenbruck G, Beuth HJ, Oette K et al. (1986) Lektine und die Organotropie der Metastasierung. Dtsch Med Wschr 111: 991–995

    Article  PubMed  CAS  Google Scholar 

  63. Urushihara H, Ikawa Y, Tsuruo T (1984) Adhesive properties of weakly and highly metastatic melanoma cell lines. Gan 75: 534–539

    PubMed  CAS  Google Scholar 

  64. Vierbuchen M (1987) Lektinhistochemie - Ein neues diagnostisches Prinzip in der Pathologie und Biologie. Verh Dtsch Ges Pathol 71: 492–502

    CAS  Google Scholar 

  65. Walther HE (1948) Krebsmetastasen. Schwabe, Basel

    Google Scholar 

  66. Yogeeswaran G, Salk PL (1981) Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 212: 1514–1516

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fischer, R., Vierbuchen, M. (1991). Biologie und Pathologie fortgeschrittener Tumoren. In: Pichlmaier, H., Müller, J.M., Jonen-Thielemann, I. (eds) Palliative Krebstherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75783-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75783-9_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-75784-6

  • Online ISBN: 978-3-642-75783-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics